Chastre Biolab SRL
Chastre Biolab reported total assets of 595,783 € at the end of the 2025 financial year (annual accounts filed with the NBB on 08 Jul 2026).
The score of Chastre Biolab shows with a free account.
See the score- Summary? / 5
- Balance sheet strength
- Liquidity
- Repayment capacity
- Profitability
- Trajectory
- Compliance and register
- Position in its sectorvs peers
- Supplier creditat 30 d
- Borrowing capacityborrowable
- Valuationcentral
Visible once signed in: create your account, the 14-day Pro trial is free.
Key figures 2025
Change 2022 → 2025: Equity +65 % Total assets +24 %
Accounts of the company itself (not consolidated).
The full file covers 8 financial years; a free account shows 2. →Deterministic calculation on the filed accounts, no AI. Dispute the score or report an error
Chastre Biolab's annual accounts
| 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|
| Net result | 158,927 € | ||||
| Equity | 456,412 € | ||||
| Cash | 466,026 € | ||||
| EBITDA | 237,913 € | ||||
| Total assets | 595,783 € |
Filed annual accounts
- Year ended 31 Dec 2025filed on 08 Jul 2026
- Year ended 31 Dec 2024filed on 30 Jun 2025
- Year ended 31 Dec 2023filed on 09 Jul 2024
- Year ended 31 Dec 2022filed on 17 Jul 2023
- Year ended 31 Dec 2021filed on 03 Aug 2022
Chastre Biolab's financial analysis
- Solvency76.6%sector median: 66.2%
- Current ratio
- Net margin
- ROE
- Financial debt / EBITDA
- Interest coverage
- Days sales outstanding (DSO)
Management and control of Chastre Biolab
Chastre Biolab's publications in the Belgian Gazette
Company number, VAT number and registered office
- Company number (CBE)
- 0685.992.413
- VAT number
- BE0685992413
- Peppol
- Not found on Peppol as of 10 Nov 2026 · Check
- Legal form
- SRL
- Incorporated
- 15 Dec 2017
- Registered office
- 1450 Chastre
- Latest accounts
- 2025 · filed on 08 Jul 2026
- Activity
- Diagnostic imaging services and medical laboratory activities (NACE 86910)
Chastre Biolab (SRL) has been based in Chastre since 2017, active in: diagnostic imaging services and medical laboratory activities. For 2025, it reports a net profit of 158,927 € and equity of 456,412 €; its revenue is not published. Its solvency stands at 76.6%, above the median of its sector (66.2%).
Companies similar to Chastre Biolab
Companies in the same business, of comparable size and area, outside its group.
- Société Immobilière de la Woluwe Woluwe-Saint-Lambert · balance sheet 595,689 €
- Docteur DANDOIS, radiodiagnostic Manufacture of basic pharmaceutical products Thuin · balance sheet 596,110 €
- Praktijk Valeo Other education n.e.c. Ostend · balance sheet 595,300 €
- Immo DE Bock Waasmunster · balance sheet 596,543 €
- Cabinet Médical Medéconomou Braine-le-Château · balance sheet 595,771 €
- Sagreljo Zonnebeke · balance sheet 596,397 €
Frequently asked questions about Chastre Biolab
What is the revenue of Chastre Biolab?
Chastre Biolab files its accounts in a format where revenue is optional: it is not published for 2025.
What is the VAT number of Chastre Biolab?
In Belgium, the VAT number is the company number prefixed with BE: BE0685992413 for Chastre Biolab, if the company is VAT-registered. Its company number (CBE) is 0685.992.413.
Where is the registered office of Chastre Biolab?
According to the CBE register, the registered office of Chastre Biolab is in 1450 Chastre.
What is the equity of Chastre Biolab?
At the close of the 2025 financial year, the equity of Chastre Biolab amounts to 456,412 €, a solvency of 76.6% of total assets.
Who manages Chastre Biolab?
The register lists 1 active mandates at Chastre Biolab. Names and roles are in the full file, with the deeds published in the Belgian Gazette.
The full file of Chastre Biolab
Directors and mandates, ownership network, Gazette deeds, ten years of accounts and ratios, Excel export, and Idonis's analysis in one question.
Open the full file →